Drug & intervention

sodium zirconium cyclosilicate 5000 MG Powder for Oral Suspension

RxCUI 2047633

What this record represents

SCD · RxNorm

This is an RxNorm SCD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.

What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.

Inspect the RxNorm source identifier

Related drug records

RxNorm name matches

These are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.

sodium zirconium cyclosilicate 5000 MG Powder for Oral Suspension [Lokelma]SBD · CureCurrent ID 67212

Molecular structure

Active ingredient: sodium zirconium cyclosilicate
Molecular structure illustration of sodium zirconium cyclosilicate
RxNorm RxCUI 2047628 · PubChem CID 155804812 · Na2O9Si3Zr. Verify structure at PubChem. This drawing represents the matched chemical ingredient, not necessarily a complete multi-ingredient branded product.
Clinical trials0
Recruiting0
Related conditions0
Synonyms2
Advertisement

Active ingredients and chemical structures

RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.

2D chemical structure of sodium zirconium cyclosilicate sodium zirconium cyclosilicate RxCUI 2047628 · Ingredient View ingredient recordPubChem CID 155804812

Conditions being studied

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.